Skip to main content

ADVERTISEMENT

Gary M. Ansel, MD, FACC

Conference Coverage
01/24/2018
Superficial femoral artery (SFA) is an area of intense research interest and multiple options for treatment. In this Q&A, Gary Ansel, MD, FACC, explains the takeaways from recently released data on various devices and therapies.
Superficial femoral artery (SFA) is an area of intense research interest and multiple options for treatment. In this Q&A, Gary Ansel, MD, FACC, explains the takeaways from recently released data on various devices and therapies.
Superficial femoral artery (SFA)...
01/24/2018
Vascular Disease Management
Interview
09/05/2008
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
An 83-year old male with an infrarenal abdominal aortic aneurysm (AAA) and right iliac aneurysm underwent coil embolization of the proximal right hypogastric artery followed by stent grafting of the AAA.
An 83-year old male with an infrarenal abdominal aortic aneurysm (AAA) and right iliac aneurysm underwent coil embolization of the proximal right hypogastric artery followed by stent grafting of the AAA.
An 83-year old male with an...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
Hepatic artery dissection is an uncommon clinical event with few reported cases in the literature. Although rare, most reported dissections have occurred in the setting of intra-arterial hepatic artery chemotherapy or as a complication of...
Hepatic artery dissection is an uncommon clinical event with few reported cases in the literature. Although rare, most reported dissections have occurred in the setting of intra-arterial hepatic artery chemotherapy or as a complication of...
Hepatic artery dissection is an...
09/05/2008
Vascular Disease Management
Surmodics Video Presentation
Presentation
03/17/2023
Gary Ansel, MD joins Bruce Gray, DO and Joseph Griffin, MD to describe their experience with the Surmodics™ Pounce™ Thrombectomy System and review various cases demonstrating removal of arterial thrombi and emboli using this solution.
Gary Ansel, MD joins Bruce Gray, DO and Joseph Griffin, MD to describe their experience with the Surmodics™ Pounce™ Thrombectomy System and review various cases demonstrating removal of arterial thrombi and emboli using this solution.
Gary Ansel, MD joins Bruce Gray,...
03/17/2023
Vascular Disease Management
Letters to the Editor
02/05/2014
Future well-designed and executed randomized control trials that track clinically relevant outcomes, including the cost of the endovascular treatments and long-term outcomes, will enable physicians to determine the optimal therapies for...
Future well-designed and executed randomized control trials that track clinically relevant outcomes, including the cost of the endovascular treatments and long-term outcomes, will enable physicians to determine the optimal therapies for...
Future well-designed and...
02/05/2014
Vascular Disease Management
CLI Perspectives
07/27/2016
In CLI, the CTO is never straightforward and tends to be associated with many additional obstacles. With us during this issue is Gary Ansel, MD, who has had a long history of treating CTOs and has pioneered many of the currently used CTO...
In CLI, the CTO is never straightforward and tends to be associated with many additional obstacles. With us during this issue is Gary Ansel, MD, who has had a long history of treating CTOs and has pioneered many of the currently used CTO...
In CLI, the CTO is never...
07/27/2016
Cath Lab Digest